Feb 01, 2018

Notice Concerning the Difference Regarding Individual Financial Results as Compared to Actual Results for the Previous Year

Name of listed company: Chugai Pharmaceutical Co., Ltd.
Code number: 4519 (1st Section of Tokyo Stock Exchange)
Head office: 1-1, Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo
Chairman & CEO: Osamu Nagayama
Inquiries to: Masahiko Uchida,
General Manager, Corporate Communications Dept.
Tel:+81-(0)3-3273-0881

Chugai Pharmaceutical Co., Ltd. hereby announces that there is a difference regarding the individual financial results (Japanese standard) for the year ended December 2017 (Jan. 1, 2017 – Dec. 31, 2017) as compared to the actual results for the previous year (Jan. 1, 2016 – Dec. 31, 2016).

1.Difference between the actual results for the year ended December 2017 and the actual results for the previous year

RevenuesOperating IncomeOrdinary IncomeNet IncomeEarnings per
Share
Actual results for the previous year (A)
(Year ended Dec. 2016)
(millions of yen)
486,903
(millions of yen)
69,048
(millions of yen)
73,289
(millions of yen)
50,907
(Yen Sen)
93.21
Actual results for this year (B)
(Year ended Dec. 2017)
(millions of yen)
526,052
(millions of yen)
86,583
(millions of yen)
91,772
(millions of yen)
69,723
(Yen Sen)
127.57
Change(B-A) (millions of yen)
39,149
(millions of yen)
17,535
(millions of yen)
18,483
(millions of yen)
18,816
-
Change(%) 8.0 25.4 25.2 37.0 -

2. Reasons for the difference occurring
The difference occurred mainly due to the strong performance of mainstay products, improvement in cost of sales from changes in product mix, and increase in royalties and other operating income.

Contact:

  • For Media
  • Chugai Pharmaceutical Co., Ltd.
  • Media Relations Group, Corporate Communications Dept.,
  • Koki Harada
  • Tel: +81-3-3273-0881
  • E-mail: pr@chugai-pharm.co.jp
  • For Investors
  • Chugai Pharmaceutical Co., Ltd.
  • Investor Relations Group, Corporate Communications Dept.,
  • Toshiya Sasai
  • Tel: +81-3-3273-0554
  • E-mail: ir@chugai-pharm.co.jp
  • Like
  • Tweet
  • LINE it!
  • E-mail
Back to top